About Artelo Biosciences Inc
- Industry: Pharmaceuticals
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://artelobio.com/
Frequently Asked Questions
What is the 52-week range for ARTL?
The 52-week high is $179.19 and the 52-week low is $3.45.
What is the P/E ratio for ARTL?
The P/E ratio data is currently unavailable.
What is the dividend yield for ARTL?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is -92.30%.
What is the Net Profit Margin?
Net Margin data is currently unavailable.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 1.20.
Analyst Recommendation Trends
Wall Street analyst consensus for ARTL over the last few months:
Latest ARTL News
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Firefly Neuroscience (NASDAQ:AIFF) shares increased by 33.2% to $1.58 during Friday's regular session. The company's market cap stands at $18.6 million. Apimeds Pharmaceuticals (AMEX:APUS) shares moved
Keep an eye on the top gainers and losers in Thursday's session.
Here are the top movers in Thursday's session, showcasing the stocks with significant price changes.
Which stocks are moving on Thursday?
Wondering how the US markets performed in the middle of the day on Thursday? Discover the movers and shakers of today's session in our comprehensive analysis.
The market is filled with gapping stocks in Thursday's session.
The market is buzzing with gapping stocks on Thursday. Let's uncover which stocks are experiencing notable gaps during today's session.
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Apimeds Pharmaceuticals (AMEX:APUS) shares increased by 162.4% to $6.01 during Thursday's regular session. The market value of their outstanding shares is at $3.4 million. Surrozen (NASDAQ:SRZN) stock
Wondering what's happening in today's pre-market session?
As the US market prepares to open on Thursday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.
Dow Tumbles Over 100 Points; US Jobless Claims Fall to 197,000
U.S. stocks fell Thursday as tech slid; jobless claims beat estimates. Oil rose, while APUS surged 245% and BENF plunged 33%.
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Profusa (NASDAQ:PFSA) stock increased by 112.5% to $4.36 during Thursday's pre-market session. The company's market cap stands at $1.2 million. GlucoTrack (NASDAQ:GCTK) stock rose 96.55% to $3.99. The
Why GlucoTrack Shares Are Trading Higher By Around 118%; Here Are 20 Stocks Moving Premarket
GlucoTrack surged 117.7% premarket after Lokahi Therapeutics signed its first external partnership; other stocks saw notable gains and losses.
Stay updated with the stocks that are on the move in today's after-hours session.
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
Let's take a look at the stocks that are in motion in today's session.
Let's have a look at what is happening on the US markets one hour before the close of the markets on Wednesday. Below you can find the top gainers and losers in today's session.
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers GlucoTrack (NASDAQ:GCTK) stock moved upwards by 90.6% to $3.87 during Wednesday's after-market session. The market value of their outstanding shares is at $1.7 million. Greenland Mines (NASDAQ:GRML) shares
Artelo Biosciences (ARTL) Stock Surges Wednesday: What's Happening?
Artelo Biosciences, Inc. (NASDAQ: ARTL) shares are surging Wednesday afternoon after the clinical-stage biopharmaceutical company announced the filing of a new provisional patent application covering its drug candidate ART27.13 for the treatment of obesity.
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Artelo Biosciences (NASDAQ:ARTL) shares rose 216.1% to $13.12 during Wednesday's regular session. The market value of their outstanding shares is at $2.2 million. Vistagen Therapeutics (NASDAQ:VTGN) shares
Artelo Biosciences Files New Provisional Patent Application Covering ART27.13 for Obesity, Alone and in Combination with GLP-1 Receptor Agonists, Following Unexpected Nonclinical Findings
As reported, ART27.13 produced approximately 40% weight loss in combination with semaglutide and approximately 20% as monotherapy, comparable to semaglutide, in obese mice over four weeks Application expands Artelo’s intellectual property position for ART27.13 into obesity, where J.P. Morgan has projected the global GLP-1 market could reach $200 billion by 2030 New findings show the combination further improved oral glucose tolerance and increased bone mineral density, an effect not observed in
Artelo Biosciences Files Provisional Patent Application For ART27.13 As Monotherapy And In Combination With GLP-1 Receptor Agonists
As reported, ART27.13 produced approximately 40% weight loss in combination with semaglutide and approximately 20% as monotherapy, comparable to semaglutide, in obese mice over four weeksApplication expands Artelo’s
Keep an eye on the top gainers and losers in Wednesday's session.
Curious to know what's happening on the US markets in the middle of the day on Wednesday? Join us as we explore the top gainers and losers in today's session.
Artelo Cannabinoid Drug Doubles Weight Loss When Paired with Popular Obesity Drug
Artelo Biosciences shares new nonclinical data showing its oral cannabinoid drug ART27.13 matches semaglutide weight loss in obese mice.
Artelo Biosciences Announces ART27.13 Achieved Weight Loss Comparable to Semaglutide as a Monotherapy and Doubled Weight Loss in Combination with Semaglutide in a Nonclinical Model of Obesity
Once-daily, oral ART27.13 reduced body weight by approximately 20% in obese mice, matching the weight loss achieved with semaglutide, the active ingredient in Ozempic® and Wegovy® Combining ART27.13 with semaglutide produced approximately 40% weight loss – double that of semaglutide alone Results indicate that ART27.13 may possess the profile of a “metabolic regulator” capable of differentially modifying body weight and other parameters depending on the metabolic phenotype being treated SOLANA B
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers DataMEDS AI (NASDAQ:MEDS) shares rose 124.1% to $3.63 during Wednesday's pre-market session. The company's market cap stands at $4.9 million. Tempest Therapeutics (NASDAQ:TPST) stock moved upwards by
Artelo Biosciences to Present at the H.C. Wainwright 28th Annual Global Investment Conference
SOLANA BEACH, Calif., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL) (“Artelo” or the “Company”), a clinical-stage pharmaceutical company focused on modulating lipid-signalling pathways to develop treatments for people living with cancer, pain, dermatologic, or neurological conditions, today announced that Gregory D. Gorgas, CEO of Artelo Biosciences, will be participating in the H.C. Wainwright 28th Annual Global Investment Conference being held September 14-16, 2026
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Immuron (NASDAQ:IMRN) stock increased by 64.9% to $1.83 during Friday's pre-market session. The company's market cap stands at $8.9 million. Akanda (NASDAQ:AKAN) shares increased by 27.52% to $4.68.
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-07-17 | Blayney Douglas | +136 | - | - |
| 2026-07-17 | Reyes Gregory | +136 | - | - |
| 2026-07-17 | Kelly Steven | +136 | - | - |
| 2026-07-17 | FAVORITO TAMARA A | +136 | - | - |
| 2026-07-17 | MATSUI CONNIE | +136 | - | - |
| 2026-07-17 | EMANUELE ROBERT MARTIN | +136 | - | - |
| 2026-01-30 | Blayney Douglas | +292 | - | - |
| 2026-01-30 | Reyes Gregory | +292 | - | - |
| 2026-01-30 | Kelly Steven | +292 | - | - |
| 2026-01-30 | FAVORITO TAMARA A | +292 | - | - |
| 2026-01-30 | MATSUI CONNIE | +292 | - | - |
| 2026-01-30 | EMANUELE ROBERT MARTIN | +292 | - | - |
| 2026-01-29 | Spring Mark Edward | +36,391 | - | - |
| 2026-01-29 | Gorgas Gregory D. | +154,713 | - | - |
| 2025-10-28 | Gorgas Gregory D. | 0 | $27710 | - |
| 2025-10-28 | Gorgas Gregory D. | +17,952 | - | - |
| 2025-10-28 | Gorgas Gregory D. | +9,586 | - | - |
| 2025-10-28 | Gorgas Gregory D. | 0 | $35000 | - |
| 2025-10-28 | FAVORITO TAMARA A | 0 | $19793 | - |
| 2025-10-28 | FAVORITO TAMARA A | +12,566 | - | - |
| 2025-10-28 | FAVORITO TAMARA A | +6,846 | - | - |
| 2025-10-28 | FAVORITO TAMARA A | 0 | $25000 | - |
| 2025-10-28 | MATSUI CONNIE | 0 | $110843 | - |
| 2025-10-28 | MATSUI CONNIE | +70,376 | - | - |
| 2025-10-28 | MATSUI CONNIE | +38,346 | - | - |
| 2025-10-28 | MATSUI CONNIE | 0 | $140000 | - |